BIO-key International, Inc.
FAIR PRICE VALUATION
Updated daily
Model: DCF 50% · Relative 30% · Consensus 20%
MARKET PRICE
$4.36
FAIR PRICE
$0.76
MARGIN
$3.60
P/E Ratio
N/A
Div. Yield
N/A
ROE
-73.3%
Average
Market Cap
$3M
Small-cap
NOW AVAILABLE
Get notified when BKYI's fair price changes
Push notifications when BKYI's valuation shifts. Available on iOS and Android.
FPI RATING
Consistent growth trajectory and attractive valuation, but weak profitability margins and volatile earnings pattern.
Analytical data, not an investment recommendation. Updated daily.
How we calculate this ↗MARGIN OF SAFETY
A 20% margin of safety below fair value — the conservative entry level for risk-aware investors.
SAFETY MARGIN
20%
Below fair value
ENTRY LEVEL
$0.61
Fair price × 0.80
DISTANCE
86.1%
Price to entry level
At the current price of $4.36, BKYI trades 86.1% above the conservative entry level of $0.61. This entry level represents a 20% margin of safety below the calculated fair price of $0.76 — a buffer that accounts for estimation uncertainty in the valuation model.
Margin of safety is a risk management concept, not an investment recommendation. The 20% threshold follows Benjamin Graham's value investing framework. Fair price and entry levels are model-based estimates updated daily. Learn more about Margin of Safety ↗
VALUATION HISTORY
Loading chart data...
P/E RATIO HISTORY
Loading chart data...
METHODOLOGY
How we calculate BKYI's fair price
BIO-key International, Inc.'s fair price of $0.76 is derived from a blended model that combines DCF analysis (50%), relative valuation against Industrials peers using metrics like P/E and EV/EBITDA (30%), and analyst consensus (20%). At the current market price of $4.36, BKYI trades 82.6% above its calculated fair value.
DCF MODEL · 50%
Discounted free cash flow analysis based on projected cash flows, discounted at a rate reflecting BKYI's risk profile.
RELATIVE · 30%
Comparing BKYI's valuation multiples against Industrials peers to determine if the stock is over or undervalued relative to its industry.
ANALYST · 20%
Aggregated analyst price targets for BKYI, weighted by recency and analyst accuracy.
TRY IT YOURSELF
Want to test your own assumptions? Use our free calculators to estimate BKYI's fair value with your own inputs.
LEARN MORE
POWERED BY BULIOS
Get full analysis, financials, and AI insights for BKYI.
Explore on BuliosFAQ
What is the fair price of BKYI?+
Based on our blended model combining DCF analysis (50%), relative valuation against Industrials peers (30%), and analyst consensus (20%), the fair price for BIO-key International, Inc. is $0.76. At the current market price of $4.36, BKYI trades 82.6% above its calculated fair value.
Is BKYI overvalued or undervalued?+
BIO-key International, Inc. is currently overvalued based on our valuation model. The stock trades at $4.36, which is 82.6% above the fair price of $0.76.
What is the margin of safety for BKYI?+
With a 20% margin of safety applied to the fair price of $0.76, the conservative entry level for BKYI is $0.61. At the current market price of $4.36, the stock trades 86.1% above this entry level. Margin of safety is a risk management concept from Benjamin Graham's value investing framework, not an investment recommendation.
How often is BKYI's fair price updated?+
We update fair price calculations for BKYI daily after market close. The current fair price of $0.76 incorporates the latest market data and sector multiples.
What factors affect BKYI's fair price calculation?+
BKYI's fair price of $0.76 is derived from DCF analysis (50% weight), relative valuation against Industrials peers (30% weight), and analyst consensus (20% weight)., ROE of -73.3%.
Is BKYI a good buy right now?+
At $4.36, BKYI trades 82.6% above our fair value estimate of $0.76. The stock is currently overvalued. ROE stands at -73.3% (average). Fair Price Index provides valuation data — always do your own research before investing.
Does BKYI pay dividends?+
BKYI does not currently pay a dividend.
RELATED STOCKS
Fair Price Index is for informational purposes only and does not constitute investment advice. Fair value calculations are model-based estimates and may not reflect actual market conditions. Always conduct your own research before making investment decisions.